4.8 Article

Cancer - Ins and outs of tumour control

期刊

NATURE
卷 454, 期 7204, 页码 586-587

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/454586a

关键词

-

向作者/读者索取更多资源

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Multidisciplinary Sciences

Whole-body imaging of lymphovascular niches identifies pre-metastatic roles of midkine

David Olmeda, Daniela Cerezo-Wallis, Erica Riveiro-Falkenbach, Paula C. Pennacchi, Marta Contreras-Alcalde, Nuria Ibarz, Metehan Cifdaloz, Xavier Catena, Tonantzin G. Calvo, Estela Canon, Direna Alonso-Curbelo, Javier Suarez, Lisa Osterloh, Osvaldo Grana, Francisca Mulero, Diego Megias, Marta Canamero, Jorge L. Martinez-Torrecuadrada, Chandrani Mondal, Julie Di Martino, David Lora, Ines Martinez-Corral, J. Javier Bravo-Cordero, Javier Munoz, Susana Puig, Pablo Ortiz-Romero, Jose L. Rodriguez-Peralto, Sagrario Ortega, Maria S. Soengas

NATURE (2017)

Article Oncology

The potential predictive value of DEK expression for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer

J. Martinez-Useros, I. Moreno, M. J. Fernandez-Acenero, M. Rodriguez-Remirez, A. Borrero-Palacios, A. Cebrian, T. Gomez del Pulgar, L. del Puerto-Nevado, W. Li, A. Puime-Otin, N. Perez, M. S. Soengas, J. Garcia-Foncillas

BMC CANCER (2018)

Article Oncology

p62/SQSTM1 Fuels Melanoma Progression by Opposing mRNA Decay of a Selective Set of Pro-metastatic Factors

Panagiotis Karras, Erica Riveiro-Falkenbach, Estela Canon, Cristina Tejedo, Tonantzin G. Calvo, Raul Martinez-Herranz, Direna Alonso-Curbelo, Metehan Cifdaloz, Eva Perez-Guijarro, Gonzalo Gomez-Lopez, Pilar Ximenez-Embun, Javier Munoz, Diego Megias, David Olmeda, Jorge Moscat, Pablo L. Ortiz-Romero, Jose L. Rodriguez-Peralto, Maria S. Soengas

CANCER CELL (2019)

Article Biochemistry & Molecular Biology

KLF9-dependent ROS regulate melanoma progression in stage-specific manner

Archis Bagati, Sudha Moparthy, Emily E. Fink, Anna Bianchi-Smiraglia, Dong Hyun Yun, Masha Kolesnikova, Olga O. Udartseva, David W. Wolff, Matthew V. Roll, Brittany C. Lipchick, Zhannan Han, Nadezhda I. Kozlova, Peter Jowdy, Albert E. Berman, Neil F. Box, Cesar Rodriguez, Wiam Bshara, Eugene S. Kandel, Maria S. Soengas, Gyorgy Paragh, Mikhail A. Nikiforov

ONCOGENE (2019)

Correction Oncology

UNR/CSDE1 Drives a Post-transcriptional Program to Promote Melanoma Invasion and Metastasis (vol 30, pg 694, 2016)

Laurence Wurth, Panagiotis Papasaikas, David Olmeda, Nadine Bley, Guadalupe T. Calvo, Santiago Guerrero, Daniela Cerezo-Wallis, Javier Martinez-Useros, Maria Garcia-Fernandez, Stefan Huttelmaier, Maria S. Soengas, Fatima Gebauer

CANCER CELL (2019)

Editorial Material Oncology

Lymph: (Fe)rrying Melanoma to Safety

Amanda W. Lund, Maria S. Soengas

CANCER CELL (2020)

Article Biochemistry & Molecular Biology

Midkine rewires the melanoma microenvironment toward a tolerogenic and immune-resistant state

Daniela Cerezo-Wallis, Marta Contreras-Alcalde, Kevin Troule, Xavier Catena, Cynthia Mucientes, Tonantzin G. Calvo, Estela Canon, Cristina Tejedo, Paula C. Pennacchi, Sabrina Hogan, Peter Koelblinger, Hector Tejero, Andrew X. Chen, Nuria Ibarz, Osvaldo Grana-Castro, Lola Martinez, Javier Munoz, Pablo Ortiz-Romero, Jose L. Rodriguez-Peralto, Gonzalo Gomez-Lopez, Fatima Al-Shahrour, Raul Rabadan, Mitchell P. Levesque, David Olmeda, Maria S. Soengas

NATURE MEDICINE (2020)

Article Oncology

The State of Melanoma: Emergent Challenges and Opportunities

Michael B. Atkins, Clara Curiel-Lewandrowski, David E. Fisher, Susan M. Swetter, Hensin Tsao, Julio A. Aguirre-Ghiso, Maria S. Soengas, Ashani T. Weeraratna, Keith T. Flaherty, Meenhard Herlyn, Jeffrey A. Sosman, Hussein A. Tawbi, Anna C. Pavlick, Pamela B. Cassidy, Sunandana Chandra, Paul B. Chapman, Adil Daud, Zeynep Eroglu, Laura K. Ferris, Bernard A. Fox, Jeffrey E. Gershenwald, Geoffrey T. Gibney, Douglas Grossman, Brent A. Hanks, Douglas Hanniford, Eva Hernando, Joanne M. Jeter, Douglas B. Johnson, Samir N. Khleif, John M. Kirkwood, Sancy A. Leachman, Darren Mays, Kelly C. Nelson, Vernon K. Sondak, Ryan J. Sullivan, Glenn Merlino

Summary: MRF conducted an assessment of challenges and opportunities in melanoma research community and patients five years ago, significant progress has been made since then. However, high incidence, recurrence, and death rates for melanoma remain. The Scientific Advisory Council and Breakthrough Consortium reconvened to discuss thematic areas essential to melanoma researchers and patients, helping to understand the challenges and opportunities facing the broader melanoma community today.

CLINICAL CANCER RESEARCH (2021)

Review Oncology

Melanoma models for the next generation of therapies

E. Elizabeth Patton, Kristen L. Mueller, David J. Adams, Niroshana Anandasabapathy, Andrew E. Aplin, Corine Bertolotto, Marcus Bosenberg, Craig J. Ceo, Christin E. Burd, Ping Chi, Meenhard Herlyn, Sheri L. Holmen, Florian A. Karreth, Charles K. Kaufman, Shaheen Khan, Sebastian Kobold, Eleonora Leucci, Carmit Levy, David B. Lombard, Amanda W. Lund, Kerrie L. Marie, Jean-Christophe Marine, Richard Marais, Martin McMahon, Carla Daniela Robles-Espinoza, Ze'ev A. Ronai, Yardena Samuels, Maria S. Soengas, Jessie Villanueva, Ashani T. Weeraratna, Richard M. White, Iwei Yeh, Jiyue Zhu, Leonard Zon, Marc S. Hurlbert, Glenn Merlino

Summary: The current state of melanoma models encompass various types which can address challenges such as metastasis, drug resistance, immune response, etc. Building models for rare subtypes of melanomas is an important yet unmet need.

CANCER CELL (2021)

Review Pharmacology & Pharmacy

Physiological models for in vivo imaging and targeting the lymphatic system: Nanoparticles and extracellular vesicles

David Olmeda, Daniela Cerezo-Wallis, Elena Castellano-Sanz, Susana Garcia-Silva, Hector Peinado, Maria S. Soengas

Summary: Imaging of the lymphatic vasculature is crucial in understanding various diseases, particularly in cancer. Activation of lymphatic endothelial cells plays a key role in therapeutic strategies. Current research focuses on visualizing the lymphatic system through imaging technologies and targeting it with drugs.

ADVANCED DRUG DELIVERY REVIEWS (2021)

Article Medicine, Research & Experimental

Live imaging of neolymphangiogenesis identifies acute antimetastatic roles of dsRNA mimics

David Olmeda, Daniela Cerezo-Wallis, Cynthia Mucientes, Tonantzin G. Calvo, Estela Canon, Direna Alonso-Curbelo, Nuria Ibarz, Javier Munoz, Jose L. Rodriguez-Peralto, Pablo Ortiz-Romero, Sagrario Ortega, Maria S. Soengas

Summary: Through live imaging experiments in mouse models, this study identified double-stranded RNA mimics as effective inhibitors of neolymphangiogenesis, metastasis, and disease relapse. Mechanistically, these RNA mimics exert a suppressive function by involving cell-autonomous type I interferon signaling, which is not shared by FDA-approved antimelanoma treatments.

EMBO MOLECULAR MEDICINE (2021)

Editorial Material Multidisciplinary Sciences

Cell position matters for tumour-driving mutations

Jean-Christophe Marine, Maria S. Soengas

NATURE (2022)

Article Multidisciplinary Sciences

Lipid droplet degradation by autophagy connects mitochondria metabolism to Prox1-driven expression of lymphatic genes and lymphangiogenesis

Odeta Mece, Diede Houbaert, Maria-Livia Sassano, Tania Durre, Hannelore Maes, Marco Schaaf, Sanket More, Maarten Ganne, Melissa Garcia-Caballero, Mila Borri, Jelle Verhoeven, Madhur Agrawal, Kathryn Jacobs, Gabriele Bergers, Silvia Blacher, Bart Ghesquiere, Mieke Dewerchin, Johan V. Swinnen, Stefan Vinckier, Maria S. Soengas, Peter Carmeliet, Agnes Noel, Patrizia Agostinis

Summary: Autophagy plays a crucial role in maintaining the homeostasis and promoting lymphangiogenesis of lymphatic endothelial cells (LEC) by supporting fatty acid oxidation and preserving the mitochondrial-PROX1 gene expression circuit.

NATURE COMMUNICATIONS (2022)

Article Immunology

T cell-derived interleukin-22 drives the expression of CD155 by cancer cells to suppress NK cell function and promote metastasis

Daria Briukhovetska, Javier Suarez-Gosalvez, Cornelia Voigt, Anamarija Markota, Anastasios D. Giannou, Maryam Schuebel, Jakob Jobst, Tao Zhang, Janina Doerr, Florian Maerkl, Lina Majed, Philipp Jie Mueller, Peter May, Adrian Gottschlich, Nicholas Tokarew, Juran Luecke, Arman Oner, Melanie Schwerdtfeger, David Andreu-Sanz, Ruth Gruenmeier, Matthias Seifert, Stefanos Michaelides, Michael Hristov, Lars M. Koenig, Bruno Loureiro Cadilha, Oleg Mikhaylov, Hans-Joachim Anders, Simon Rothenfusser, Richard A. Flavell, Daniela Cerezo-Wallis, Cristina Tejedo, Maria S. Soengas, Tobias Bald, Samuel Huber, Stefan Endres, Sebastian Kobold

Summary: Although T cells producing interleukin-22 (IL-22) in breast and lung tumors are associated with poor patient outcomes, deletion of IL-22 or its receptor reduces metastasis in mouse models. IL-22 induces high expression of CD155, which impairs the function of NK cells and increases metastatic burden. The findings suggest an immunosuppressive circuit activated by T cell-derived IL-22 that promotes lung metastasis.

IMMUNITY (2023)

Article Oncology

ATG5 Mediates a Positive Feedback Loop between Wnt Signaling and Autophagy in Melanoma

Abibatou Ndoye, Anna Budina-Kolomets, Curtis H. Kugel, Marie R. Webster, Amanpreet Kaur, Reeti Behera, Vito W. Rebecca, Ling Li, Patricia A. Brafford, Qin Liu, Y. N. Vashisht Gopal, Michael A. Davies, Gordon B. Mills, Xiaowei Xu, Hong Wu, Meenhard Herlyn, Michael C. Nicastri, Jeffrey D. Winkler, Maria S. Soengas, Ravi K. Amaravadi, Maureen E. Murphy, Ashani T. Weeraratna

CANCER RESEARCH (2017)

暂无数据